Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patientsLisa Rice, Robert Lafyatis|Journal of Clinical Investigation|2015Cited by 343
Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skinTracy Tabib, Robert Lafyatis|Nature Communications|2021Cited by 257